Literature DB >> 514051

[Effect of isoniazid and rifampicin regimens on the liver of tuberculosis patients].

J A Pilheu, M C De Salvo, J A Barcat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 514051

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN： 0025-7680            Impact factor:   0.653


× No keyword cloud information.
  4 in total

1.  A systems biology approach utilizing a mouse diversity panel identifies genetic differences influencing isoniazid-induced microvesicular steatosis.

Authors:  Rachel J Church; Hong Wu; Merrie Mosedale; Susan J Sumner; Wimal Pathmasiri; Catherine L Kurtz; Mathew T Pletcher; John S Eaddy; Karamjeet Pandher; Monica Singer; Ameesha Batheja; Paul B Watkins; Karissa Adkins; Alison H Harrill
Journal:  Toxicol Sci       Date:  2014-05-20       Impact factor: 4.849

Review 2.  Mechanism of isoniazid-induced hepatotoxicity: then and now.

Authors:  Imir Metushi; Jack Uetrecht; Elizabeth Phillips
Journal:  Br J Clin Pharmacol       Date:  2016-02-25       Impact factor: 4.335

3.  Ultrastructural changes in the parenchymal liver cells of rats treated with high doses of rifampicin.

Authors:  A Piriou; R Maissiat; A Jacqueson; J M Warnet; J R Claude
Journal:  Br J Exp Pathol       Date:  1987-04

4.  Isoniazid and Rifampicin Produce Hepatic Fibrosis through an Oxidative Stress-Dependent Mechanism.

Authors:  Ayan Biswas; Suman Santra; Debasree Bishnu; Gopal Krishna Dhali; Abhijit Chowdhury; Amal Santra
Journal:  Int J Hepatol       Date:  2020-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.